TWO SIGMA INVESTMENTS, LP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 39 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,701
-43.8%
10,876
-19.9%
0.00%
Q2 2023$15,477
-32.5%
13,576
-11.1%
0.00%
Q1 2023$22,914
-50.5%
15,276
-50.8%
0.00%
Q4 2022$46,303
-15.8%
31,076
-13.1%
0.00%
Q3 2022$55,000
-37.5%
35,776
-7.7%
0.00%
Q2 2022$88,000
-38.9%
38,776
-37.6%
0.00%
Q1 2022$144,000
-13.8%
62,184
+116.1%
0.00%
Q4 2021$167,000
-7.7%
28,771
+55.1%
0.00%
Q2 2021$181,000
-73.0%
18,551
-59.8%
0.00%
-100.0%
Q1 2021$670,00046,1120.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders